MX2014006234A - Metodo de la fertilizacion in vitro con retraso de transferencia de embriones y el uso de las celulas mononucleares de la sangre periferica. - Google Patents

Metodo de la fertilizacion in vitro con retraso de transferencia de embriones y el uso de las celulas mononucleares de la sangre periferica.

Info

Publication number
MX2014006234A
MX2014006234A MX2014006234A MX2014006234A MX2014006234A MX 2014006234 A MX2014006234 A MX 2014006234A MX 2014006234 A MX2014006234 A MX 2014006234A MX 2014006234 A MX2014006234 A MX 2014006234A MX 2014006234 A MX2014006234 A MX 2014006234A
Authority
MX
Mexico
Prior art keywords
peripheral blood
patient
mononuclear cells
blood mononuclear
embryo
Prior art date
Application number
MX2014006234A
Other languages
English (en)
Inventor
Alexander Feskov
Irina Feskova
Ievgeniia Zhylkova
Stanislav Zhilkov
Original Assignee
Mezadata Medical Ip Holding Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mezadata Medical Ip Holding Llp filed Critical Mezadata Medical Ip Holding Llp
Publication of MX2014006234A publication Critical patent/MX2014006234A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/42—Gynaecological or obstetrical instruments or methods
    • A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
    • A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D19/00—Instruments or methods for reproduction or fertilisation
    • A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46431—Contraceptive or sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins

Abstract

Un método de la fertilización in vitro en donde el embrión es implantado en el útero de una paciente de sexo femenino al menos dos, y preferiblemente de tres a doce meses después de que los óvulos son extraídos de la paciente con el fin de reducir el efecto del rechazo autoinmune del embrión por el sistema autoinmune de la paciente e incrementar la probabilidad y éxito del embarazo, y en donde antes de la implantación del embrión, el endometrio en el útero es preparado para la implantación del embrión por medio de la introducción de las células mononucleares de sangre periférica (PBMCs) en el útero. El procedimiento se combina con técnicas de criopreservación para preservar los ovocitos o los embriones producidos por FIV de la paciente.
MX2014006234A 2011-11-23 2012-11-21 Metodo de la fertilizacion in vitro con retraso de transferencia de embriones y el uso de las celulas mononucleares de la sangre periferica. MX2014006234A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161629651P 2011-11-23 2011-11-23
US13/655,257 US10271876B2 (en) 2011-11-23 2012-10-18 Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
PCT/US2012/066258 WO2013078312A1 (en) 2011-11-23 2012-11-21 Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells

Publications (1)

Publication Number Publication Date
MX2014006234A true MX2014006234A (es) 2015-02-10

Family

ID=48470292

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014006234A MX2014006234A (es) 2011-11-23 2012-11-21 Metodo de la fertilizacion in vitro con retraso de transferencia de embriones y el uso de las celulas mononucleares de la sangre periferica.

Country Status (14)

Country Link
US (3) US10271876B2 (es)
EP (1) EP2782993A4 (es)
KR (1) KR20140113917A (es)
CN (2) CN104126004A (es)
AU (2) AU2012340647A1 (es)
BR (1) BR112014012533A2 (es)
CA (2) CA2856860C (es)
EA (1) EA038427B1 (es)
IL (2) IL232784A0 (es)
MD (1) MD4526C1 (es)
MX (1) MX2014006234A (es)
UA (1) UA143229U (es)
WO (1) WO2013078312A1 (es)
ZA (1) ZA201404498B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3037101B1 (en) 2014-12-22 2019-03-06 Ferring B.V. Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
CA3035055A1 (en) 2016-08-29 2018-03-08 Progena, Inc. Autologous somatic stem cell therapy, method of controllable preparation of therapeutic composition and procedure of adaptive treatment of ivf patient
CN110361534B (zh) * 2018-03-26 2023-11-03 山大生殖研发中心有限公司 评估胚胎和预测体外受精成功率的化学标记物和其应用
RU2714124C1 (ru) * 2019-06-24 2020-02-12 Галина Александровна Суханова Способ проведения экстракорпорального оплодотворения
JP2022553069A (ja) * 2019-10-25 2022-12-21 インテレクソン ゲゼルシャフト ミット ベシュレンクテル ハフツング ｉｎ ｖｉｔｒｏ受精におけるＨＬＡクラスＩ分子とさらなる医学的意義
US20230154608A1 (en) * 2021-11-17 2023-05-18 Optum, Inc. Machine learning techniques for predictive endometriosis-based prediction
KR102599957B1 (ko) 2022-11-16 2023-11-09 주식회사 코스모스웨일 보조생식술 성공률 향상을 위한 배아이식용 배양액 조성물 및 이의 제조 방법

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56342A (en) 1978-12-29 1982-05-31 Zer Tamar Method and means for determining human chorionic gonadotropin in urine
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
WO1990008188A1 (en) 1989-01-10 1990-07-26 Amrad Corporation Limited Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
AU8505398A (en) * 1997-07-23 1999-02-16 Northeastern University Methods for enhancing or reducing preimplantation embryo survival rates
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
AUPP421298A0 (en) 1998-06-19 1998-07-09 Fertilitescentrum Ab Method and medium for in vitro culture of human embryos
WO2000032140A1 (en) * 1998-11-30 2000-06-08 Ivf Sciences Colorado, Inc. System and sequential culture media for in vitro fertilization
EP1231836A4 (en) * 1999-11-17 2004-06-02 Univ Rochester EX VIVO HUMAN IMMUNE SYSTEM
IL160780A0 (en) 2001-09-12 2004-08-31 Applied Research Systems USE OF hCG IN THE MANUFACTURE OF A MEDICAMENT
NZ518163A (en) * 2002-04-05 2005-04-29 Kiwi Ingenuity Ltd Embryo modified with a glycolipid to enhance implantation into the endometrium
JP2005529609A (ja) 2002-06-17 2005-10-06 ケベンハウンス・アムツ・シゲフス・ハーレウ 体外受精
CA2505394C (en) 2002-11-07 2014-05-13 University Of Chicago Human stem cell materials and methods
JP3762975B2 (ja) 2003-03-18 2006-04-05 学校法人慶應義塾 単球由来多能性細胞ｍｏｍｃ
CA2553673A1 (en) 2003-08-28 2005-03-10 Reprocure, Llc Method for determining embryo quality
US20050118363A1 (en) * 2003-09-26 2005-06-02 Fuji Photo Film Co., Ltd. Heat transfer recording material
WO2005094576A2 (en) * 2004-03-25 2005-10-13 Community Hospitals Of Indiana, Inc. Cryopreservation media
US20050241013A1 (en) * 2004-04-22 2005-10-27 Geoffrey Sher Unique use of sHLA-G obtained in soluble form from JEG-3 cell line, by purification by PCR, HPLC, or any other techniques, as well as in other forms, as an implantation promoting agent when added to embryo culture and/or to the media in which embryos are transferred to the uterus following in vitro fertilization
SI1765085T1 (sl) 2004-05-17 2015-11-30 The General Hospital Corporation Sestavki, ki vsebujejo ženske zarodne matične celice in postopki njihove uporabe
EP1765987A4 (en) 2004-06-11 2008-05-07 Kiwi Ingenuity Ltd ENZYMATIC MODIFICATION OF CELL SURFACE ANTIGEN H BY GLYCOSYL TRANSFERASES
US8232077B2 (en) * 2005-07-06 2012-07-31 Ovacyte Llc Oocytes derived from ovarian culture initially containing no oocytes
US8183214B2 (en) 2005-09-21 2012-05-22 Kode Biotech Limited Cell surface coating with hyaluronic acid oligomer derivative
GB0601746D0 (en) * 2006-01-27 2006-03-08 Novocellus Ltd Cryopreservation method
WO2008148105A1 (en) * 2007-05-25 2008-12-04 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
US20100239539A1 (en) * 2009-03-23 2010-09-23 Sing George L Methods for promoting differentiation and differentiation efficiency
US9815124B1 (en) 2016-03-22 2017-11-14 Flamur Tulovic Hole saw with threadably removable portion

Also Published As

Publication number Publication date
EP2782993A1 (en) 2014-10-01
AU2018203649B2 (en) 2020-10-08
MD4526B1 (ro) 2017-11-30
WO2013078312A1 (en) 2013-05-30
MD20140060A2 (en) 2014-11-30
US20220039834A1 (en) 2022-02-10
AU2012340647A1 (en) 2014-06-19
IL276077A (en) 2020-08-31
EA201490996A1 (ru) 2015-02-27
CA3079719A1 (en) 2013-05-30
CA2856860A1 (en) 2013-05-30
CA2856860C (en) 2020-07-07
ZA201404498B (en) 2015-08-26
EP2782993A4 (en) 2015-04-15
US11957384B2 (en) 2024-04-16
US20190110813A1 (en) 2019-04-18
KR20140113917A (ko) 2014-09-25
CN110295143A (zh) 2019-10-01
IL232784A0 (en) 2014-07-31
UA143229U (uk) 2020-07-27
US20130172666A1 (en) 2013-07-04
US10271876B2 (en) 2019-04-30
CN104126004A (zh) 2014-10-29
US11185348B2 (en) 2021-11-30
BR112014012533A2 (pt) 2017-06-06
MD4526C1 (ro) 2018-09-30
EA038427B1 (ru) 2021-08-27
AU2018203649A1 (en) 2018-06-07

Similar Documents

Publication Publication Date Title
MX2014006234A (es) Metodo de la fertilizacion in vitro con retraso de transferencia de embriones y el uso de las celulas mononucleares de la sangre periferica.
Lonergan et al. Maturation of oocytes in vitro
Borchersen et al. Danish AI field data with sexed semen
Morrell Artificial insemination: current and future trends
Kouba et al. Assisted reproductive technologies (ART) for amphibians
EP1731177A4 (en) BIOLOGICAL TISSUE SHEET, METHOD OF FORMATION THEREOF AND TRANSPLANTATION METHOD USING THE SHEET
Skidmore The use of some assisted reproductive technologies in old world camelids
Unuma et al. Optimum temperature of rearing water during artificial induction of ovulation in Japanese eel
Youssefi et al. More male calves born after Presynch-Ovsynch protocol with 24-hour timed AI in dairy cows
NZ792553A (en) Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
WO2018044789A8 (en) Autologous somatic stem cell therapy, method of controllable preparation of therapeutic composition and procedure of adaptive treatment of ivf patient
Hussein et al. Preliminary study of factors affecting the superovulatory response of high producing dairy cows superstimulated regardless of the stage of estrous cycle in Egypt
EA202191332A1 (ru) Метод экстракорпорального оплодотворения с отсрочкой переноса эмбриона и использованием мононуклеарных клеток периферической крови
CN102174467A (zh) 一种小鼠卵巢组织液的提取方法及其应用
CN103343142B (zh) 一种利用连续克隆技术生产孤雌生殖克隆猪的方法
WO2011096775A3 (ko) 소 생식세포와 임신증진물질을 동시 장착 후 1회로 자궁내에 주입이 가능한 2단 인공수정기
Mooyottu et al. Ovarian stem cells and neo-oogenesis: A breakthrough in reproductive biology research
Yokoo et al. Near-infrared laser irradiation improves the development of mouse pre-implantation embryos
RU2018114660A (ru) Применение циклического трипептида для улучшения клеточного энергетического метаболизма
CN105483079A (zh) 基于体外受精的小鼠微生物净化方法
CN107841484A (zh) 一种体外卵母细胞培养体系及其应用
Lindeberg embryo technology in the farmed european polecat (Mustela putorius)
Jadoun et al. Reproductive biotechnology in small ruminants-A review
Hufana-Duran et al. In Vitro Embryo Production in Water Buffalo
Gagsteiger et al. Making the embryologist’s life easier during intracytoplasmatic sperm injection (ICSI): use of dimethylxanthine theophylline (SpermMobil®) for testicular sperm samples